A novel EGFR nonsense mutation in a non-small-cell lung cancer (NSCLC) patient who did not derive any clinical benefit with combination chemotherapy and erlotinib
Ramón González Manzano, Elena Martínez Navarro, Elena Eugenieva, Francisco José Fernández Morejón, José Farré, Antonio BrugarolasVolume:
10
Language:
english
Pages:
3
DOI:
10.1007/s12094-008-0229-2
Date:
July, 2008
File:
PDF, 276 KB
english, 2008